drugset / Trial / NCT01269021
An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)
RandomizedParallel-groupOpen-labelTreatment
Summary
In order to treat proliferative IgA Nephropathy(IgAN), The investigators designed an open, prospective, randomized parallel study to access the efficacy and safety of MMF compared to corticosteroid . Patients who fulfill the inclusion criteria will be randomized in a 1:1 ratio to either the MMF group or corticosteroid group.
Timeline
- Start
- 2010-11
- Primary completion
- 2013-10
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Mofetil | Small molecule | 1 g | — |
| Subject | Mycophenolate Mofetil | Small molecule | 1.5 g | — |
| Comparator | Prednisone | Other / unclassified | 0.4 mg/kg | — |
| Comparator | Prednisone | Other / unclassified | 0.6 mg/kg | — |
| Comparator | Prednisone | Other / unclassified | 0.8 mg/kg | — |
| Comparator | Prednisone | Other / unclassified | 1 mg/kg | — |